Open Chemistry > 2005 > 3 > 1 > 157-168
Source
Abstract
Identifiers
journal ISSN : | 2391-5420 |
DOI | 10.2478/BF02476246 |
Authors
Keywords
Additional information
Publisher
Fields of science
Bibliography
-
RELATION NAME
-
[2] P. Köpf-Maier: “Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma”, Anticancer Res., Vol. 19, (1999), pp. 493–504.
-
[3] K. Mross, P. Robben-Bathe, L. Edler, J. Baumgart, W. E. Berdel, H. Fiebig and C. Unger: “Phase I clinical trial of a day −1, −3, −5 every 3 weeks schedule with titanocene dichloride (MKT 5) in patients with advanced cancer: A study of the phase I study group of the Association for Medical Oncology (AIO) of the German Cancer Society”, Onkologie, Vol. 23, (2000), pp. 576–579. http://dx.doi.org/10.1159/000055009